Clinical Trial: Comparison of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous Doses of GZR33 Injection and Insulin Aspart

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918898) titled 'Comparison of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous Doses of GZR33 Injection and Insulin Aspart' on Oct. 27.

Brief Summary: This trial is conducted in China. This study will be conducted to evaluate pharmacokinetic/pharmacodynamic characteristics and safety of single administration of GZR101-80 Injection with separately injected, simultaneous doses of GZR33 Injection and Insulin Aspart in healthy participants

Study Start Date: Oct. 29

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: GZR101 80 Injection

Single dose. ...